Three tumor antigens (CCR4, TMCO1, and SPACA4) related to APCs infiltration and prognosis in HNSCC were identified, and it is expected that these genes might become candidate antigens for an mRNA vaccine. This evidence concerns the gene SPACA4 and head and neck squamous cell carcinoma.